Foresite Capital Fund IV, L.P.'s Form 4 filing
Eikon Therapeutics, Inc. (EIKN) · filed Feb 6, 2026
- Accession no.
- 0001104659-26-011662
- Filed
- Feb 6, 2026, 7:37 PM ET
- Trade date
- Feb 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 15 non-derivative transactions and 14 derivative transactions. Open-market purchases total $1.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foresite Capital Fund IV, L.P.CIK 0001704131 | 10% Owner |
| Foresite Capital Management IV, LLCCIK 0001704132 | 10% Owner |
| Foresite Capital Fund V, L.P.CIK 0001792204 | 10% Owner |
| Foresite Capital Opportunity Fund V, L.P.CIK 0001792205 | 10% Owner |
| Foresite Capital Management V, LLCCIK 0001792206 | 10% Owner |
| Foresite Capital Opportunity Management V, LLCCIK 0001792207 | 10% Owner |
| Foresite Capital VI-A, LLCCIK 0001899120 | 10% Owner |
| Foresite Capital VI-A Management, LLCCIK 0001899218 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Common Stock | CConversionAcquired | +1,340,878 | $0.00 | $0 | 1,340,878 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +335,521 | $0.00 | $0 | 1,676,399 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +37,855 | $0.00 | $0 | 1,714,254 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +229,428 | $0.00 | $0 | 1,943,682 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +697,885 | $0.00 | $0 | 697,885 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +37,855 | $0.00 | $0 | 735,740 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +1,626 | $0.00 | $0 | 737,366 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +67,207 | $0.00 | $0 | 804,573 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +458,855 | $0.00 | $0 | 1,263,428 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +348,942 | $0.00 | $0 | 348,942 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +37,855 | $0.00 | $0 | 386,797 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +922 | $0.00 | $0 | 387,719 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +38,133 | $0.00 | $0 | 425,852 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionAcquired | +408,725 | $0.00 | $0 | 408,725 | Indirect | |
| Feb 4, 2026 | Common Stock | PPurchaseAcquired | +55,555 | $18.00 | +$999,990 | 1,318,983 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Common Stock | CConversionDisposed | −1,340,878 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −335,521 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −697,885 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −348,942 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −37,855 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −37,855 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −37,855 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −408,725 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −1,626 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −922 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −67,207 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −38,133 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −229,428 | $0.00 | $0 | 0 | Indirect | |
| Feb 4, 2026 | Common Stock | CConversionDisposed | −458,855 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.